Regulatory

Bayer HealthCare LLC is facing a class-action lawsuit filed in April in California alleging that the company’s Phillips Probiotics Colon Health dietary supplement makes unsupported claims for digestive and immune health.

According to the FTC, Daniel Chapter One and Feijo deceptively advertised that four dietary supplements inhibit tumor formation or growth, eliminate tumors, treat or cure cancer, or heal the effects of radiation or chemotherapy.

If you manufacture a product with phytosterols, beware. A series of recent regulatory developments is giving the health claim a face lift.